dihexa hgf c met potentiator HGF-independent potentiation of EGFR action by c-Met An overview of the c-MET
An overview of the c MET signaling pathway PMC Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Targeting cancer associated fibroblast activated HGF c MET pathway inhibits extrahepatic cholangiocarcinoma progression and restores gemcitabine therapeutic sensitivity ScienceDirect Facilitation of the Brain Hepatocyte Growth Factor C Met Receptor System: A New Approach to Treat Alzheimer's Disease?
Pay in 4 interest-free payments of $5.78 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9


